ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

PASG Passage Bio Inc

1.31
-0.03 (-2.24%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Passage Bio Inc PASG NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.03 -2.24% 1.31 13:00:11
始値 安値 高値 終値 前日終値
1.34 1.30 1.38 1.31 1.34
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2220:00GLOBEPassage Bio to Present at Chardan’s 8th Annual Genetic..
2024/3/0521:00GLOBEPassage Bio Seeks Pennsylvania College Student Candidates..
2024/3/0507:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0506:09EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/3/0421:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0421:02EDGAR2Form 8-K - Current report
2024/3/0421:00GLOBEPassage Bio Reports Fourth Quarter and Full-Year 2023..
2024/3/0106:06EDGAR2Form 8-K - Current report
2024/2/2721:00GLOBEPassage Bio to Participate in Upcoming Investor Conferences
2024/2/1423:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1409:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1409:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0606:05EDGAR2Form 8-K - Current report
2024/1/0406:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/3006:15EDGAR2Form 8-K - Current report
2023/12/2021:05EDGAR2Form 8-K - Current report
2023/12/2021:00GLOBEPassage Bio Announces Promising Initial Data From Phase 1/2..
2023/11/1806:30GLOBEPassage Bio Announces Inducement Grant Under Nasdaq Listing..
2023/11/1321:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1321:00EDGAR2Form 8-K - Current report
2023/11/1321:00GLOBEPassage Bio Reports Third Quarter 2023 Financial Results and..
2023/10/3020:00GLOBEPassage Bio to Present at Guggenheim’s 5th Annual..
2023/10/2105:30GLOBEPassage Bio Announces Inducement Grants Under Nasdaq Listing..
2023/9/2520:00GLOBEPassage Bio to Present at Chardan’s 7th Annual Genetic..
2023/9/0205:10EDGAR2Form 8-K - Current report
2023/8/0720:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0720:15GLOBEPassage Bio Reports Second Quarter 2023 Financial Results..
2023/8/0720:15EDGAR2Form 8-K - Current report
2023/8/0720:00GLOBEPassage Bio Announces Promising Interim Clinical Data from..
2023/8/0205:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0120:00GLOBEPassage Bio to Participate in Upcoming Investor Conferences
2023/8/0106:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0106:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/7/3120:00GLOBEPassage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of..
2023/7/2907:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2020:00EDGAR2Form 8-K - Current report
2023/6/0520:00GLOBEPassage Bio to Present at Goldman Sachs 44th Annual Global..
2023/5/1120:00GLOBEPassage Bio Reports First Quarter 2023 Financial Results and..

最近閲覧した銘柄

Delayed Upgrade Clock